<bill session="115" type="h" number="4825" updated="2019-04-18T16:19:43Z">
  <state datetime="2018-01-18">REFERRED</state>
  <status>
    <introduced datetime="2018-01-18"/>
  </status>
  <introduced datetime="2018-01-18"/>
  <titles>
    <title type="official" as="introduced">To improve medical research on marijuana.</title>
    <title type="short" as="introduced">Marijuana Effective Drug Studies Act of 2018</title>
    <title type="short" as="introduced">Marijuana Effective Drug Studies Act of 2018</title>
    <title type="short" as="introduced">MEDS Act</title>
    <title type="short" as="introduced">MEDS Act</title>
    <title type="display">MEDS Act</title>
  </titles>
  <sponsor bioguide_id="B001250"/>
  <cosponsors>
    <cosponsor bioguide_id="B000574" joined="2018-01-18"/>
    <cosponsor bioguide_id="C001068" joined="2018-02-23"/>
    <cosponsor bioguide_id="C001114" joined="2018-01-18"/>
    <cosponsor bioguide_id="F000465" joined="2018-04-26"/>
    <cosponsor bioguide_id="G000578" joined="2018-02-26"/>
    <cosponsor bioguide_id="K000389" joined="2018-06-05"/>
    <cosponsor bioguide_id="L000584" joined="2018-01-18"/>
    <cosponsor bioguide_id="M000312" joined="2018-02-26"/>
    <cosponsor bioguide_id="N000147" joined="2018-01-18"/>
    <cosponsor bioguide_id="P000613" joined="2018-02-06"/>
    <cosponsor bioguide_id="P000598" joined="2018-01-18"/>
    <cosponsor bioguide_id="R000606" joined="2018-01-18"/>
    <cosponsor bioguide_id="R000409" joined="2018-02-06"/>
    <cosponsor bioguide_id="R000608" joined="2018-02-06"/>
    <cosponsor bioguide_id="S001192" joined="2018-01-18"/>
  </cosponsors>
  <actions>
    <action datetime="2018-01-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-01-18" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-01-18">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-01-19">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-01-24">
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSJU" name="House Judiciary" activity="Referral"/>
    <committee subcommittee="Crime, Terrorism, and Homeland Security" code="HSJU08" name="House Judiciary" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="115" relation="unknown" number="1803"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Alternative treatments"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Health personnel"/>
    <term name="Licensing and registrations"/>
    <term name="Medical research"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2018-01-18T05:00:00Z" status="Introduced in House">Marijuana Effective Drug Studies Act of 2018 or the MEDS Act

This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.

Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.</summary>
  <committee-reports/>
</bill>
